germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
IF: 2,319<br />
<strong>Fundació</strong> <strong>Institut</strong> <strong>d'Investigació</strong><br />
<strong>en</strong> <strong>Ciències</strong> <strong>de</strong> la Salut<br />
Germans Trias i Pujol<br />
Santarpia M, Altavilla G, Salazar F, Taron M, Rosell R.<br />
From the b<strong>en</strong>ch to the bed: individualizing treatm<strong>en</strong>t in non‐small‐cell lung cancer.<br />
Clin Transl Oncol 2006;8:71‐6<br />
IF:<br />
Sastre J, Aranda E, Abad A, Gallego J, Manzano JL, Gomez A, Carrato A, Lopez E, Diaz‐Rubio E; TTD Group.<br />
UFT in combination with oxaliplatin: clinical phase I study in pati<strong>en</strong>ts with advanced or metastatic solid tumors.<br />
ANTI‐CANCER DRUG 2006 Apr;17(4):417‐21<br />
IF: 2,245<br />
Sirera R, Camps C, Llobat L, Berrocal A, Munoz‐Navarro M, Blasco A, Safont MJ, Gar<strong>de</strong> J, Juarez A, Taron M, Rosell<br />
R.<br />
The quantification of the catalytic subunit of telomerase is a prognostic factor in advanced non‐small cell lung<br />
cancer (NSCLC) pati<strong>en</strong>ts.<br />
LUNG CANCER‐J IASLC 52:S28‐S28.<br />
IF: 3,554<br />
Sirera R, Camps C, Llobat L, Munoz‐Navarro M, Marroqui A, Blasco A, Safont MJ, Gar<strong>de</strong> J, Taron M, Alberola V,<br />
Rosell R.<br />
Prognostic value of blood levels of vascular <strong>en</strong>dothelial growth factor (VEGF) and basic fibroblast growth factor<br />
(bFGF) in advanced non‐small cell lung cancer. In: Lung Cancer.<br />
LUNG CANCER‐J IASLC p. S28‐S28.<br />
IF: 3,554<br />
Vela E, Roca X, Isamat M.<br />
Id<strong>en</strong>tification of novel splice variants of the human CD44 g<strong>en</strong>e.<br />
BIOCHEM BIOPH RES CO 343(1):167‐170.<br />
IF: 2,855<br />
Weiss GJ, Langer C, Rosell R, Hanna N, Shepherd F, Einhorn LH, Nguy<strong>en</strong> B, Paul S, McAndrews P, Bunn PA Jr, Kelly<br />
K.<br />
El<strong>de</strong>rly pati<strong>en</strong>ts b<strong>en</strong>efit from second‐line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial<br />
of pemetrexed compared with docetaxel in pati<strong>en</strong>ts with previously treated advanced non‐small‐cell lung cancer.<br />
J CLIN ONCOL 2006 Sep 20;24(27):4405‐11<br />
IF: 13,598<br />
Zhong DS, Guo LZ, <strong>de</strong> Aguirre I, Liu XJ, Lamb N, Sun SY, Gal AA, Vertino PM, Zhou W.<br />
LKB1 mutation in large cell carcinoma of the lung.<br />
LUNG CANCER‐J IASLC 53(3):285‐294.<br />
IF: 3,554<br />
Hemopaties malignes i trasplantam<strong>en</strong>t <strong>de</strong> prog<strong>en</strong>itors hematopoètics<br />
Alvarez I, Sureda A, Caballero MD, Urbano‐Ispizua A, Ribera JM, Canales M, Garcia‐Con<strong>de</strong> J, Sanz G, Arranz R,<br />
Bernal MT, <strong>de</strong> la Serna J, Diez JL, Moraleda JM, Rubio‐Felix D, Xicoy B, Martinez C, Mateos MV, Sierra J.<br />
Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin lymphoma:<br />
Results of a Spanish prospective cooperative protocol.<br />
BIOL BLOOD MARROW TR 2006; 12(2):172‐183.<br />
IF: 3,458<br />
Pàgina 72/177
Change language